John C Martin - Net Worth and Insider Trading
John C Martin Net Worth
The estimated net worth of John C Martin is at least $280 Million dollars as of 2024-11-10. John C Martin is the Director of Gilead Sciences Inc and owns about 2,877,762 shares of Gilead Sciences Inc (GILD) stock worth over $278 Million. John C Martin is also the Director of Kronos Bio Inc and owns about 1,952,364 shares of Kronos Bio Inc (KRON) stock worth over $2 Million. Details can be seen in John C Martin's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that John C Martin has not made any transactions after 2020-10-14 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of John C Martin
John C Martin Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, John C Martin owns 3 companies in total, including Kronos Bio Inc (KRON) , Sarepta Therapeutics Inc (SRPT) , and Gilead Sciences Inc (GILD) .
Click here to see the complete history of John C Martin’s form 4 insider trades.
Insider Ownership Summary of John C Martin
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
KRON | Kronos Bio Inc | 2020-10-14 | director |
SRPT | Sarepta Therapeutics Inc | 2020-01-13 | director |
GILD | Gilead Sciences Inc | 2018-12-03 | director & Chairman and CEO |
John C Martin Latest Holdings Summary
John C Martin currently owns a total of 2 stocks. Among these stocks, John C Martin owns 2,877,762 shares of Gilead Sciences Inc (GILD) as of December 3, 2018, with a value of $278 Million and a weighting of 99.42%. John C Martin also owns 1,952,364 shares of Kronos Bio Inc (KRON) as of October 14, 2020, with a value of $2 Million and a weighting of 0.58%.
Latest Holdings of John C Martin
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
GILD | Gilead Sciences Inc | 2018-12-03 | 2,877,762 | 96.57 | 277,891,088 |
KRON | Kronos Bio Inc | 2020-10-14 | 1,952,364 | 0.83 | 1,610,700 |
Holding Weightings of John C Martin
John C Martin Form 4 Trading Tracker
According to the SEC Form 4 filings, John C Martin has made a total of 0 transactions in Gilead Sciences Inc (GILD) over the past 5 years. The most-recent trade in Gilead Sciences Inc is the sale of 50,000 shares on December 3, 2018, which brought John C Martin around $4 Million.
According to the SEC Form 4 filings, John C Martin has made a total of 1 transactions in Kronos Bio Inc (KRON) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Kronos Bio Inc is the acquisition of 75,800 shares on October 14, 2020, which cost John C Martin around $1 Million.
Insider Trading History of John C Martin
- 1
John C Martin Trading Performance
GuruFocus tracks the stock performance after each of John C Martin's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by John C Martin is 1.24%. GuruFocus also compares John C Martin's trading performance to market benchmark return within the same time period. The performance of stocks bought by John C Martin within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how John C Martin's insider trading performs compared to the benchmark.
Performance of John C Martin
John C Martin Ownership Network
Ownership Network List of John C Martin
Ownership Network Relation of John C Martin
John C Martin Owned Company Details
What does Kronos Bio Inc do?
Who are the key executives at Kronos Bio Inc?
John C Martin is the director of Kronos Bio Inc. Other key executives at Kronos Bio Inc include director & 10 percent owner & President & CEO Norbert W Bischofberger , COO & General Counsel Barbara Kosacz , and Chief Scientific Officer Christopher Dinsmore .
Kronos Bio Inc (KRON) Insider Trades Summary
Over the past 18 months, John C Martin made no insider transaction in Kronos Bio Inc (KRON). Other recent insider transactions involving Kronos Bio Inc (KRON) include a net purchase of 5,351,696 shares made by Norbert W Bischofberger , a net sale of 40,194 shares made by Jorge Dimartino , and a net sale of 24,032 shares made by Christopher Dinsmore .
In summary, during the past 3 months, insiders sold 0 shares of Kronos Bio Inc (KRON) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 116,028 shares of Kronos Bio Inc (KRON) were sold and 5,351,696 shares were bought by its insiders, resulting in a net purchase of 5,235,668 shares.
Kronos Bio Inc (KRON)'s detailed insider trading history can be found in Insider Trading Tracker table.
Kronos Bio Inc Insider Transactions
John C Martin Mailing Address
Above is the net worth, insider trading, and ownership report for John C Martin. You might contact John C Martin via mailing address: 333 Lakeside Drive, Foster City X1 94404.